Article
IL-1 polymorphisms modulates functional recovery following rehabilitation in multiple sclerosis.
Frontiers in immunology - 1 Jan 2026
Agliardi Cristina, Guerini Franca Rosa, Zanzottera Milena, Bolognesi Elisabetta, Caputo Domenico, Groppo Elisabetta, Rovaris Marco, Clerici Mario
Abstract excerpt
Background: Interleukin-1 (IL-1) cytokines as well as IL-1 genes are key regulators of neuroinflammation in Multiple Sclerosis (MS), with emerging roles in synaptic plasticity and tissue repair. While genetic determinants of MS susceptibility have been extensively characterized, their contribution to neurofunctional recovery remains poorly understood. Objective: To investigate whether functional polymorphisms in...
Topics
Join the communities discussing this publication.
